17:07 EST Emergent BioSolutions sees Q1 revenue $200M-$250M, consensus $185.4M
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EBS:
- Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
- Emergent BioSolutions Secures Flexible Credit Terms and Guarantor
- Emergent BioSolutions options imply 25.1% move in share price post-earnings
- Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
- Biotech Alert: Searches spiking for these stocks today
Questions or Comments about the article? Write to editor@tipranks.com